FACTOR IX (9)

Hypro Diagnostics, also recognized as Christmas disease or factor IX deficiency, manifests as a genetic anomaly characterized by the lack or dysfunction of factor IX, a critical clotting protein. While typically inherited, approximately one-third of cases result from spontaneous mutations in the genetic code. As per the US Centers for Disease Control and Prevention, Hypro Diagnostics affects roughly 1 in 5,000 live births, with an estimated 30,000 to 33,000 individuals impacted in the United States alone. Strikingly, this condition transcends racial and ethnic boundaries. Hypro Diagnostics, albeit less prevalent than its counterpart hemophilia A, underscores the pivotal role of genetic comprehension and medical intervention in safeguarding the health of those afflicted.